ID OCI-Ly1 AC CVCL_1879 SY OCI-LY1; OCI-ly1; OCI-LY-1; OCI-Ly-1; Oci-Ly-1; OCI-Ly 1; OCI-Ly01; OCI Ly1; Ly1; LY1 DR EFO; EFO_0005907 DR BioGRID_ORCS_Cell_line; 1211 DR cancercelllines; CVCL_1879 DR ChEMBL-Cells; CHEMBL4295427 DR ChEMBL-Targets; CHEMBL4296480 DR Cosmic; 1134602 DR Cosmic; 1295512 DR Cosmic; 1329091 DR Cosmic; 1517641 DR Cosmic; 1541900 DR Cosmic; 1629932 DR Cosmic; 1636682 DR Cosmic; 1945183 DR Cosmic; 2276318 DR DSMZ; ACC-722 DR DSMZCellDive; ACC-722 DR ENCODE; ENCBS397COL DR ENCODE; ENCBS729LWO DR ENCODE; ENCBS899DSB DR ENCODE; ENCBS945KYE DR GEO; GSM1957 DR GEO; GSM380130 DR GEO; GSM552450 DR GEO; GSM1035341 DR GEO; GSM1059803 DR GEO; GSM1374783 DR GEO; GSM3150250 DR Lonza; 1352 DR PRIDE; PXD012087 DR Progenetix; CVCL_1879 DR PubChem_Cell_line; CVCL_1879 DR Wikidata; Q54931759 RX PubMed=3567358; RX PubMed=8574164; RX PubMed=10676951; RX PubMed=11807979; RX PubMed=12169673; RX PubMed=19278952; RX PubMed=19358282; RX PubMed=20628145; RX PubMed=23257783; RX PubMed=23292937; RX PubMed=23699601; RX PubMed=25960936; CC From: Ontario Cancer Institute (OCI); Toronto; Canada. CC Doubling time: ~50-60 hours (DSMZ=ACC-722). CC HLA typing: A*02:01; C*05:01,05:01 (PubMed=25960936). CC Omics: Genomics; ChIP-seq; H3K9ac. CC Omics: Genomics; Whole exome sequencing. CC Omics: Genomics; Whole genome sequencing. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; miRNA profiling; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; Array-based CGH. CC Omics: Variations; CNV analysis. CC Omics: Variations; SNP array analysis. CC Misspelling: Ocl-Ly1; GEO=GSM3150250. CC Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. ST Source(s): DSMZ=ACC-722 ST Amelogenin: X,Y ST CSF1PO: 10,11 ST D13S317: 12 ST D16S539: 9 ST D18S51: 12 ST D19S433: 13,15 ST D21S11: 29,30 ST D2S1338: 21,24 ST D3S1358: 16,17 ST D5S818: 11,12 ST D7S820: 11 ST D8S1179: 8,15 ST FGA: 21,22 ST Penta D: 9,11 ST Penta E: 7,10 ST TH01: 9.3 ST TPOX: 8,9 ST vWA: 15,16 DI NCIt; C8851; Diffuse large B-cell lymphoma DI ORDO; Orphanet_544; Diffuse large B-cell lymphoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG 44Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 32 // RX PubMed=20628145; DOI=10.1182/blood-2010-05-282780; PMCID=PMC2995356; RA Green, Michael Richard RA Monti, Stefano RA Rodig, Scott J. RA Juszczynski, Przemyslaw RA Currie, Treeve RA O'Donnell, Evan RA Chapuy, Bjoern RA Takeyama, Kunihiko RA Neuberg, Donna RA Golub, Todd Robert RA Kutok, Jeffery L. RA Shipp, Margaret Ann RT "Integrative analysis reveals selective 9p24.1 amplification, RT increased PD-1 ligand expression, and further induction via JAK2 in RT nodular sclerosing Hodgkin lymphoma and primary mediastinal large RT B-cell lymphoma."; RL Blood 116:3268-3277(2010). // RX PubMed=23292937; DOI=10.1073/pnas.1205299110; PMCID=PMC3557051; RA Zhang, Jenny RA Grubor, Vladimir RA Love, Cassandra L. RA Banerjee, Anjishnu RA Richards, Kristy L. RA Mieczkowski, Piotr Andrzej RA Dunphy, Cherie RA Choi, William Wai-Lap RA Au, Wing Yan RA Srivastava, Gopesh RA Lugar, Patricia Lynne RA Rizzieri, David A. RA Lagoo, Anand S. RA Bernal-Mizrachi, Leon RA Mann, Karen P. RA Flowers, Christopher Robert RA Naresh, Kikkeri N. RA Evens, Andrew M. RA Gordon, Leo I. RA Czader, Magdalena Beata RA Gill, Javed Iqbal RA Hsi, Eric Darryl RA Liu, Qing-Quan RA Fan, Alice RA Walsh, Katherine RA Jima, Dereje RA Smith, Lisa L. RA Johnson, Amy J. RA Byrd, John C. RA Luftig, Micah Alan RA Ni, Ting RA Zhu, Jun RA Chadburn, Amy RA Levy, Shawn RA Dunson, David Brian RA Dave, Sandeep S. RT "Genetic heterogeneity of diffuse large B-cell lymphoma."; RL Proc. Natl. Acad. Sci. U.S.A. 110:1398-1403(2013). // RX PubMed=19358282; DOI=10.1002/ijc.24351; RA Inagaki, Atsushi RA Ishida, Takashi RA Yano, Hiroki RA Ishii, Toshihiko RA Kusumoto, Shigeru RA Ito, Asahi RA Ri, Masaki RA Mori, Fumiko RA Ding, Jian-Min RA Komatsu, Hirokazu RA Iida, Shinsuke RA Ueda, Ryuzo RT "Expression of the ULBP ligands for NKG2D by B-NHL cells plays an RT important role in determining their susceptibility to RT rituximab-induced ADCC."; RL Int. J. Cancer 125:212-221(2009). // RX PubMed=23257783; DOI=10.1038/leu.2012.367; RA Wenzel, Soren-Sebastian RA Grau, Michael RA Mavis, Cory RA Hailfinger, Stephan RA Wolf, Annette RA Madle, Hannelore RA Deeb, George RA Dorken, Bernd RA Thome, Margot RA Lenz, Peter RA Dirnhofer, Stefan RA Hernandez-Ilizaliturri, Francisco Javier RA Tzankov, Alexandar RA Lenz, Georg RT "MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma."; RL Leukemia 27:1381-1390(2013). // RX PubMed=8574164; DOI=10.3109/10428199509059672; RA Chang, Hong RA Blondal, John A. RA Benchimol, Sam RA Minden, Mark David RA Messner, Hans August RT "p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's RT lymphoma cell lines."; RL Leuk. Lymphoma 19:165-171(1995). // RX PubMed=19278952; DOI=10.1182/blood-2009-01-202028; PMCID=PMC3401058; RA Li, Cheng RA Kim, Sang-Woo RA Rai, Deepak RA Bolla, Aswani R. RA Adhvaryu, Siddharth RA Kinney, Marsha C. RA Robetorye, Ryan S. RA Aguiar, Ricardo C.T. RT "Copy number abnormalities, MYC activity, and the genetic fingerprint RT of normal B cells mechanistically define the microRNA profile of RT diffuse large B-cell lymphoma."; RL Blood 113:6681-6690(2009). // RX PubMed=3567358; DOI=10.1182/blood.V69.5.1307.1307; RA Tweeddale, Mary Elizabeth RA Lim, Bing RA Jamal, Nazir RA Robinson, Jean RA Zalcberg, John Raymond RA Lockwood, Gina RA Minden, Mark David RA Messner, Hans August RT "The presence of clonogenic cells in high-grade malignant lymphoma: a RT prognostic factor."; RL Blood 69:1307-1314(1987). // RX PubMed=10676951; DOI=10.1038/35000501; RA Alizadeh, Ash Arash RA Eisen, Michael Bruce RA Davis, R. Eric RA Ma, Chi RA Lossos, Izidore S. RA Rosenwald, Andreas RA Boldrick, Jennifer Connolly RA Sabet, Hajeer RA Tran, Truc RA Yu, Xin RA Powell, John I. RA Yang, Li-Ming RA Marti, Gerald E. RA Moore, Troy RA Hudson, James Jr. RA Lu, Li-Sheng RA Lewis, David B. RA Tibshirani, Robert John RA Sherlock, Gavin RA Chan, Wing-Chung RA Greiner, Timothy Charles RA Weisenburger, Dennis D. RA Armitage, James Olen RA Warnke, Roger Allen RA Levy, Ronald RA Wilson, Wyndham H. RA Grever, Michael Rhodes RA Byrd, John C. RA Botstein, David RA Brown, Patrick O'Reilly RA Staudt, Louis Michael RT "Distinct types of diffuse large B-cell lymphoma identified by gene RT expression profiling."; RL Nature 403:503-511(2000). // RX PubMed=12169673; DOI=10.1016/S1525-1578(10)60693-9; PMCID=PMC1906980; RA Robetorye, Ryan S. RA Bohling, Sandra Dawn RA Morgan, John W. RA Fillmore, G. Chris RA Lim, Megan S. RA Elenitoba-Johnson, Kojo Seys John RT "Microarray analysis of B-cell lymphoma cell lines with the RT t(14;18)."; RL J. Mol. Diagn. 4:123-136(2002). // RX PubMed=25960936; DOI=10.4161/21624011.2014.954893; PMCID=PMC4355981; RA Boegel, Sebastian RA Lower, Martin RA Bukur, Thomas RA Sahin, Ugur RA Castle, John C. RT "A catalog of HLA type, HLA expression, and neo-epitope candidates in RT human cancer cell lines."; RL OncoImmunology 3:e954893.1-e954893.12(2014). // RX PubMed=23699601; DOI=10.1182/blood-2013-02-483727; PMCID=PMC3744992; RA Morin, Ryan D. RA Mungall, Karen RA Pleasance, Erin D. RA Mungall, Andrew J. RA Goya, Rodrigo RA Huff, Ryan D. RA Scott, David W. RA Ding, Jia-Rui RA Roth, Andrew RA Chiu, Readman RA Corbett, Richard D. RA Chan, Fong Chun RA Mendez-Lago, Maria RA Trinh, Diane L. RA Bolger-Munro, Madison RA Taylor, Greg RA Hadj Khodabakhshi, Alireza RA Ben-Neriah, Susana RA Pon, Julia RA Meissner, Barbara RA Woolcock, Bruce W. RA Farnoud, Noushin RA Rogic, Sanja RA Lim, Emilia L. RA Johnson, Nathalie A. RA Shah, Sohrab P. RA Jones, Steven J.M. RA Steidl, Christian RA Holt, Robert A. RA Birol, Inanc RA Moore, Richard RA Connors, Joseph M. RA Gascoyne, Randy D. RA Marra, Marco Antonio RT "Mutational and structural analysis of diffuse large B-cell lymphoma RT using whole-genome sequencing."; RL Blood 122:1256-1265(2013). // RX PubMed=11807979; DOI=10.1002/gcc.10025; RA Mehra, Sukvarsha RA Messner, Hans August RA Minden, Mark David RA Chaganti, Raju S.K. RT "Molecular cytogenetic characterization of non-Hodgkin lymphoma cell RT lines."; RL Genes Chromosomes Cancer 33:225-234(2002). //